These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3682463)

  • 21. [Retrograde protection of the myocardium in cardiac surgery].
    Semagin AP
    Khirurgiia (Mosk); 1989 Jan; (1):114-8. PubMed ID: 2649735
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of viscosity on poststenotic distribution of cardioplegic solutions.
    Landymore RW; Kinley CE
    J Thorac Cardiovasc Surg; 1984 Jun; 87(6):944-6. PubMed ID: 6610080
    [No Abstract]   [Full Text] [Related]  

  • 23. Optimal intraoperative protection of myocardium distal to coronary stenoses.
    Silverman NA; Schmitt G; Levitsky S; Feinberg H
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):424-31. PubMed ID: 6433111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Warm retrograde cardioplegia: protection of the right ventricle in mitral valve operations.
    Singh AK
    J Thorac Cardiovasc Surg; 1993 Aug; 106(2):370-1. PubMed ID: 8341080
    [No Abstract]   [Full Text] [Related]  

  • 25. Antegrade cardioplegia pressure monitoring.
    Fabri BM; Fox MA
    Ann Thorac Surg; 1997 Jul; 64(1):292. PubMed ID: 9236397
    [No Abstract]   [Full Text] [Related]  

  • 26. Aortic root pressure monitoring during antegrade cardioplegia administration.
    Young JN; Choy IO
    Ann Thorac Surg; 1996 Oct; 62(4):1213-4. PubMed ID: 8823126
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect on myocardial perfusion of simultaneous delivery of cardioplegic solution through a single coronary artery and the coronary sinus.
    Tian G; Dai G; Xiang B; Sun J; Lindsay WG; Deslauriers R
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):1004-10. PubMed ID: 11689807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of myocardial metabolism during prolonged blood cardioplegic perfusion in the surgery of acquired heart diseases].
    Gapochkina IN; Kiselev VO; Shipulin VM; Evtushenko AV; Ponomarenko IV
    Anesteziol Reanimatol; 2008; (3):7-10. PubMed ID: 18652166
    [No Abstract]   [Full Text] [Related]  

  • 29. Warm nondepolarizing adenosine and lidocaine cardioplegia: continuous versus intermittent delivery.
    Sloots KL; Vinten-Johansen J; Dobson GP
    J Thorac Cardiovasc Surg; 2007 May; 133(5):1171-8. PubMed ID: 17467425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial protection for reoperative cardiac surgery in acquired heart disease.
    Cohn LH
    Semin Thorac Cardiovasc Surg; 1993 Apr; 5(2):162-7. PubMed ID: 8481451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative assessment of temperature of the myocardium during its protection by 2 methods in aortocoronary bypass].
    Mishchenko EB; Lokshin LS; Iavorovskiĭ AG; Lur'e GO; Shabalkin BV; Zhdanov IV
    Anesteziol Reanimatol; 1995; (2):14-6. PubMed ID: 7645765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Normal-temperature artificial circulation. Warm blood cardioplegia].
    Lur'e GO; Vol'gushev VE; Lokshin LS
    Anesteziol Reanimatol; 1995; (2):25-7. PubMed ID: 7645769
    [No Abstract]   [Full Text] [Related]  

  • 33. Retrieval of crystalloid cardioplegic solutions.
    Eucher PM; Buche M; Broka S; Schoevaerdts JC
    Ann Thorac Surg; 1996 Feb; 61(2):746-7. PubMed ID: 8572811
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of myocardial ultrastructure after retrograde infusion of cardioplegic solution.
    Barner HB; Fischer VW
    J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1743-6. PubMed ID: 1453740
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of intravenous diltiazem (CRD-401) on myocardial protection--clinical experience in coronary artery revascularization].
    Sunamori M; Matsunaga H; Suzuki A
    Rinsho Kyobu Geka; 1988 Feb; 8(1):61-6. PubMed ID: 9301814
    [No Abstract]   [Full Text] [Related]  

  • 36. eComment: myocardial protection: efficacy of a novel magnesium-basedcardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution.
    Bockeria LA; Movsesyan RR; Ryabtsev DV; Grigoryants TR
    Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):749. PubMed ID: 18801803
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study of cases with prolonged aortic cross-clamping times (> 240 min) using cold K(+)-Mg++ cardioplegia].
    Tanaka H; Yoshida T; Nakagawa T; Arai H; Ohnuki M; Beh CK; Maruyama T; Okamura T; Amano J; Sakamoto T
    Rinsho Kyobu Geka; 1988 Jun; 8(3):270-4. PubMed ID: 9301844
    [No Abstract]   [Full Text] [Related]  

  • 38. Supraphysiological levels of magnesium in cardioplegic arrest solutions: is there cause for concern?
    Tyers GF
    Can J Cardiol; 1995 Jan; 11(1):21-2. PubMed ID: 7850660
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cardioprotective effects of cariporide as an adjunct in different cardioplegic solutions: an experiment with rabbits].
    Zhou RH; Long C; Liu J; Liu B
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2320-3. PubMed ID: 18036293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Myocardial protection: is retrograde equal to antegrade perfusion?].
    Tönz M; Freiburghaus AU; Redha F; Schneider J; von Segesser LK; Turina M
    Helv Chir Acta; 1993 Dec; 60(3):435-8. PubMed ID: 8119825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.